Results 41 to 50 of about 4,880 (169)
First Experience With Extravascular Implantable Cardioverter‐Defibrillator Under Deep Sedation
ABSTRACT Background The Extravascular Implantable Cardioverter‐Defibrillator (EV‐ICD) utilizes a substernal lead to provide defibrillation and anti‐tachycardia pacing (ATP) while avoiding transvenous complications. General anesthesia (GA) was applied for implantation procedures in the EV‐ICD pivotal trial and is currently recommended by the ...
Nibras Soubh +9 more
wiley +1 more source
105 Inappropriate ICD Shocks in a Patient with Dilated Cardiomyopathy and Broca’s Aphasia
With a growing number of ICD recipients, device complications are seen more frequently in the clinical setting and outpatient departments. Among the most severe are ICD infections and inappropriate therapies caused by oversensing of atrial tachycardias or lead fracture.
Christian Georgi +4 more
openaire +3 more sources
Impact of ICD Presence in Patients With Left Ventricular Assist Devices for End‐Stage Heart Failure
ABSTRACT Background The prognostic relevance of implantable cardioverter defibrillator (ICD) in patients with end‐stage heart failure (HF) with left ventricular assist device (LVAD) remains controversial. Objectives To evaluate the prognostic impact of ongoing use of ICD and associated complications in HF‐patients with LVAD‐implantation.
Nafilah Baridwan +11 more
wiley +1 more source
Monitoring zone-associated implantable cardioverter defibrillator shock: A case report
A 41-year-old man with Brugada syndrome, who had been implanted with an ATLAS+DR V-243 (St. Jude Medical, Inc., St. Paul, MN, USA) dual-chamber implantable cardioverter defibrillator (ICD) for secondary prevention of arrhythmia, received an inappropriate
Hisayasu Matsuzaki +7 more
doaj +1 more source
Immune Checkpoint Inhibitor–Related Myositis and Associated Triad Overlap Syndrome
Objective Immune checkpoint inhibitor (ICI) myositis is a rare but a highly morbid condition, particularly with the ICI myositis triad syndrome of myositis, myocarditis, and myasthenia gravis. We report the clinical characteristics of ICI myositis and all‐cause mortality in these patients.
Selene Rubino +9 more
wiley +1 more source
Inappropriate shock in a subcutaneous cardiac defibrillator due to residual air
Key Clinical Message Inappropriate shock due to residual air in subcutaneous implantable cardiac defibrillators is not a well‐known complication. Obtaining overpenetrated X‐rays, recognizing electrocardiogram findings, limiting blunt finger dissection ...
Shawn Lee +3 more
doaj +1 more source
Implantable Cardioverter Defibrillators in Octogenarians: Clinical Outcomes From a Single Center
Aims: Limited data exist on outcomes in very elderly ICD recipients. We describe outcomes in new ICD and Cardiac Resynchronisation Therapy with Defibrillator (CRT-D) implants in octogenarians at our institution.
D.G. Wilson, MB ChB +5 more
doaj +1 more source
ABSTRACT Systemic corticosteroids frequently utilized to manage lumbosacral radiculopathy introduce an immunological paradox by potentially triggering varicella‐zoster virus reactivation. While well‐documented in severely immunocompromised populations, the specific neuro‐immunological mechanisms in otherwise immunocompetent patients with lumbar disc ...
Jun Liu +11 more
wiley +1 more source
The Role of Subcutaneous ICDs in the Prevention of Sudden Cardiac Death
The ICD is an important therapy in the prevention of sudden cardiac death. The transvenous-ICD (TV-ICD) has been the primary device used for this purpose.
Leah A John +2 more
doaj +1 more source
Tachycardia detection and therapy algorithms in Implantable Cardioverter-Defibrillators (ICD) reduce, but do not eliminate inappropriate ICD shocks.
Ajit Thachil, MD, DM, CCDS +2 more
doaj +1 more source

